Список литературы
Белик И.Е. Кожная красная волчанка: классификация, диагностика, тактика ведения больных // Дерматологія та венерологія. 2009. № 3. С. 44–50.
Бертсиас Г.И. Рекомендации EULAR по лечению системной красной волчанки // Научно-практическая ревматология. 2008. № 1. С. 93–96.
Главинская Т.А. Лечение и профилактика красной волчанки и склеродермии: учебное пособие. Н. Новгород: НГМА, 2000. С. 22.
Капкаев Р.А., Селисский Г.Д., Адо В.А. Диспансеризация при кожных и венерических заболеваниях. Ташкент: Медицина, 1989. 184 с.
Красная волчанка. Клинические рекомендации РОДВК. М., 2020.
Свинцицкий А.С. Системная красная волчанка: особенности клинической симптоматики // Doctor. 2002. № 1. С. 22–26.
Скрипкин Ю.К., Бутов Ю.С., Хамаганова И.В. и др. Поражения кожи при болезнях соединительной ткани // Клиническая дерматовенерология / Под ред. Ю.К. Скрипкина, Ю.С. Бутова. М.: ГЭОТАР-Медиа, 2009. Т. II. С. 234–277.
Barikbin B., Givrad S., Yousefi M. et al. Pimecrolimus 1% cream versus betamethasone 17-valerate 0,1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized, pilot study // Clin. Exp. Dermatol. 2009. Vol. 34. N. 7. P. 776–780.
Bharti S., Dogra S., Saikia B. et al. Immunofluorescence profile of discoid lupus erythematosus // Indian J. Pathol. Microbiol. 2015. Vol. 58. P. 479–482.
Biazar C., Sigges J., Patsinakidis N. et al. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE) // Autoimmun. Rev 2013. Vol. 12. N. 3. P. 444–454.
Boehm I.B., Boehm G.A., Bauer R. Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms // Rheumatol. Int. 1998. Vol. 18. N. 2. P. 59–62.
Chang A.Y., Werth V.P. Treatment of cutaneous lupus // Curr. Rheumatol. Rep. 2011. Vol. 13. N. 4. P. 300–307.
Crowson A.N., Magro C.M. Cutaneous histopathology of lupus erythematosus // Diagn. Histopathol. 2009. Vol. 15. N. 4. P. 157–185. DOI: https://doi.org/10.1016/j.mpdhp.2009.02.006.
Drake L.A., Dinehart S.M., Farmer E.R. et al. Guidelines of care for cutaneous lupus erythematosus: American Academy of Dermatology // J. Am. Acad. Dermatol 1996. Vol. 34. N. 5. Pt 1. P. 830–836.
Ellis F.A., Bundick W.R. Histology of lupus erythematosus // AMA Arch. Derm. Syphilol. 1954. Vol. 70. N. 3. P. 311–324. DOI: https://doi.org/10.1001/archderm.1954.01540210051009.
Gronhagen C.M., Nyberg F. Cutaneous lupus erythematosus: an update // Indian Dermatol. Online J. 2014. Vol. 5. N. 1. P. 7–13.
Isfer R.S., Sanches J.A. Jr, Festa Neto C. et al. Direct immunofluorescence in lupus erythematosus (LE) // Sao Paulo Med. J. 1996. Vol. 114. N. 2. P. 1141–1147.
Jha A.K., Sonthalia S., Sarkar R. Dermoscopy of discoid lupus erythematosus // Indian Dermatol. Online J. 2016. Vol. 7. P. 458.
Juhlin L. Treatment of psoriasis and other dermatoses with a single application of a corticosteroid left under a hydrocolloid occlusive dressing for one week // Acta Derm. Venereol 1989. Vol. 69. N. 4. P. 355–357.
Kuhn A., Aberer E., Bata-Csörgö Z. et al. S2k guideline for treatment of cutaneous lupus erythematosus-guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) // J. Eur. Acad. Dermatol. Venereol. 2017. Vol. 31. N. 3. P. 389–404.
Kuhn A., Gensch K., Haust M. et al. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial // J. Am. Acad. Dermatol. 2011. Vol. 65. N. 1. P. 54–64.
Kuhn A., Landmann A. The classification and diagnosis of cutaneous lupus erythematosus // J. Autoimmun. 2014. Vol. 48–49. P. 14–19.
Kuhn A., Ochsendorf F., Bonsmann G. Treatment of cutaneous lupus erythematosus // Lupus. 2010. Vol. 19. N. 9. P. 1125–1136.
Lai N.-S., Tsai T.-Y., Koo M. et al. Patterns of ambulatory medical care utilization and rheumatologist consultation predating the diagnosis of systemic lupus erythematosus: a national population-based study // PLoS One. 2014. Vol. 9. N. 7. Article ID e101485. DOI: https://doi.org/10.1371/journal.pone.0101485.
Lallas A., Apalla Z., Lefaki I. et al. Dermoscopy of discoid lupus erythematosus // Br. J. Dermatol. 2013. Vol. 168. N. 2. P. 284–288.
Moura Filho J.P., Peixoto R.L, Martins L.G. et al. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects // An. Bras. Dermatol. 2014. Vol. 89. N. 1. P. 118–125.
Pinto-Almeida T., Sanches M., Alves R., Selores M. Vesico-bullous subacute cutaneous lupus erythematosus — an uncommon entity successfully treated with dapsone and hydroxychloroquine // Dermatol. Online J. 2012. Vol. 18. N. 8. P. 13.
Ruzicka T., Sommerburg C., Goerz G. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine // Br. J. Dermatol. 1992. Vol. 127. N. 5. P. 513–518.
Sigges J., Biazar C., Landmann A. et al. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupuserythematosus // Autoimmun. Rev. 2013. Vol. 12. N. 7. P. 694–702.